FoundationOne CDx available in the US from Mar. 30

http://investors.foundationmedicine.com/releasedetail.cfm?releaseid=1062384

FoundationOne CDx
- first US FDA-approved CGP assay for all solid tumors
- offered as a nationally covered benefit across all solid tumors for Medicare and Medicare Advantage beneficiaries https://www.medscape.com/viewarticle/894190
- technical information https://assets.ctfassets.net/vhribv12lmne/6Rt6csmCPuaguuqmgi2iY8/e3a9b0456ed71a55d2e4480374695d95/FoundationOne_CDx.pdf

댓글

이 블로그의 인기 게시물

Atezolizumab + cobimetinib in locally advanced or metastatic CRC (Phase III IMblaze370) - primary endpoint analysis

Knockout mouse; transgenic mouse; genetically engineered mouse (GEM)